Fig. 2
From: Short-acting β2-agonists (SABA) bronchodilator sales and outdoor mould in central France
a Aspergillus–Penicillium and SABA sales in 6–12 years old male children. b Alternaria and SABA sales in 6–12 years old male children. Shape of the mold-prescribed SABA sales curve from the GAMM models for Aspergillus–Penicillium and Alternaria in 6–12 years old male children. The mold-prescribed allergy SABA sales relationship (expressed as natural logarithm of the relative risk ratio [Log (RR)] can be read as the prescribed SABA sales increase on the y-axis for a mold increase on the x-axis